УРОВЕНЬ ЭКСПРЕССИИ CART-ПЕПТИДА В ЯДРАХ АМИГДАЛЫ МОЗГА КРЫСХИСМАТУЛЛИНА, З.Р.,
САДРТДИНОВА, И.И.,
ФЕДОРОВА, А.М.,
ФАЙРУШИНА, А.И.,
ДАВЛЕТБАЕВА, А.Р.,
Khismatullina, Z.R.,
Sadrtdinova, I.I.,
Fedorova, A.M.,
Fairushina, A.I.,
Davletbaeva, A.R. Целью данного исследования явилось определение уровня экспрессии
CART-белка в структурах
Антигенные рецепторы в разработке CAR-T клеток для иммунотерапии глиобластомы for glioblastoma remains poor. Chimeric Antigen Receptor T-cell (
CAR-T) therapy, which utilizes genetically
Granulocyte-macrophage colony-stimulating factor and car-t technology for solid tumors in experiment are considered as important factors that enhance the efficacy of
CAR-T cell therapy. Besides, they are key
The application of mRNA vectors for CART therapy in vivoThe application of mRNA vectors for
CART therapy
in vivo Tumor-Associated Extracellular Matrix Obstacles for CAR-T Cell Therapy: Approaches to OvercomingKlabukov I.,
Kabakov A.E.,
Yakimova A.,
Baranovskii D.,
Sosin D.,
Atiakshin D.,
Ignatyuk M.,
Yatsenko E.,
Rybachuk V.,
Evstratova E.,
Eygel D.,
Kudlay D.,
Stepanenko V.,
Shegay P.,
Kaprin A.D. Chimeric antigen receptor (
CAR)-T cell therapy yields good results in the treatment of various
Application of car-t cell therapy beyond oncology: Autoimmune diseases and viral infections on genetically engineered T lymphocytes, with chimeric antigen receptor (
CAR)-T cells as the most prominent
La carte de la gestion des ressources naturelles du district DzerjinskiLa
carte de la gestion des ressources naturelles du district Dzerjinski